DuraSeal® as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer - Abstract

The purpose of this study was to evaluate the utility of off-label use of DuraSeal® polyethylene glycol (PEG) gel in low-dose rate (LDR) prostate brachytherapy seed implantation to reduce rectal doses. Diluted DuraSeal® was easy to use and, in spite of a clearance effect, useful in decreasing D2cc rectal doses.

Written by:
Heikkilä VP, Kärnä A, Vaarala MH.   Are you the author?
Department of Radiotherapy, Oulu University Hospital, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Finland.  

Reference: Radiother Oncol. 2014 Sep 4. pii: S0167-8140(14)00334-X.
doi: 10.1016/j.radonc.2014.08.012


PubMed Abstract
PMID: 25201125

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

UroToday.com Prostate Cancer Section

email news signup